AYTU icon

AYTU BioPharma

50 hedge funds and large institutions have $26.1M invested in AYTU BioPharma in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

46% less capital invested

Capital invested by funds: $48.3M → $26.1M (-$22.2M)

58% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 24

Holders
50
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.37M
Puts
$808K
Net Calls
Net Calls Change

Top Buyers

1 +$2.21M
2 +$1.74M
3 +$510K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$480K
5
E
Ergoteles
New York
+$378K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$6.72M
2
$4.93M
3
$2.42M
4
$2.39M
5
$2.21M
6
$1.11M
7
$516K
8
$510K
9
$489K
10
$480K
11
$378K
12
$305K
13
$301K
14
$289K
15
$287K
16
$283K
17
$275K
18
$270K
19
$236K
20
$212K
21
$173K
22
$131K
23
$123K
24
$122K
25
$122K